mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |